Sentence examples for boosting of immunity from inspiring English sources

We use a dynamic mathematical model to explore biases introduced in results drawn from case-control studies of enteric pathogens by waning and boosting of immunity, and by asymptomatic infections, using Campylobacter jejuni as an example.

We evaluated whether an ELISPOT test could identify tuberculosis (TB) contacts with boosting of immunity to non-tuberculous mycobacterial exposure.

We estimate that approximately one third of tuberculin skin test conversion in Gambian TB case contacts is due to boosting of immunity to non-tuberculous mycobacterial exposure.

Our ELISPOT results suggest that approximately one third of tuberculin conversion in Gambian TB case contacts is due boosting of immunity to non-tuberculous mycobacterial exposure.

It does appear that an ELISPOT assay may have a niche in exposing boosting of immunity to non-tuberculous mycobacterial exposure.

Unlike Pfs25 and Pfs28, pre-fertilization antigens are also targets of the natural immune response and thus immunity induced by a vaccine based on any of these antigens will have the added benefit of natural boosting of immunity.

The model considers maternal protection, boosting of existing immunity, loss of immunity, and cross-immunizing events between the B lineages.

29, 30, 31 Thus, BTLA is expected to be a new target for interventions aimed at reversal of immune evasion and boosting of antitumor immunity in cancer patients.

These findings suggest that BTLA is involved in the formation of a protumor microenvironment, supporting the contention that BTLA is an important co‐inhibitory molecule in the orchestration of immunosuppressive networks in cancer, and therefore a potential new target for interventions aimed at reversal of immune evasion and boosting of antitumor immunity in cancer patients.

Repeat tuberculin skin tests may be false positive due to boosting of waned immunity to past mycobacterial exposure.

Our findings have interesting implications for current efforts to develop therapeutic strategies for NPC based on selective boosting of endogenous immunity or adoptive transfer of CTLs.